Doctor Xiaocong Marston
Shanghai (China)
Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort study
Event: ESC Congress 2020
Topic: Antiarrhythmic Drug Treatment
Session: Arrhythmias, General ePosters
ESC 365 is supported by
